Maryann Fitzgerald and Dr. Justin Jordan
Maryann was diagnosed with a stage 4 brain tumor on December 26th, 2018, and has faced her diagnosis head-on each day since with humor and grace.
About Justin Jordan, MD, MPH
Dr. Jordan earned his bachelor's degree in biology from Texas Christian University, then his MD from the University of Texas Medical School in Houston. During that time he performed basic science and translational research on brain tumor immunology at the University of Texas M.D. Anderson Cancer Center in Houston. He then completed his neurology residency at the University of Texas Southwestern Medical Center in Dallas, where he served as chief resident. He trained in the neuro-oncology fellowship at the joint program of Massachusetts General Hospital, Dana Farber Cancer Institute, and Brigham and Women's Hospital. In his second year of fellowship, he concentrated on the neurofibromatoses and allied disorders, and he simultaneously completed a Masters of Public Health degree program at the Harvard T.H. Chan School of Public Health. He joined the clinical faculty of the Pappas Center for Neuro-Oncology and the Family Center for Neurofibromatosis in February 2015, and became Clinical Director of the MGH Brain Tumor Center in July 2017 and additionally became the Director of the Family Center for Neurofibromatosis in 2020.
Dr. Jordan's clinical interests are in primary nervous system tumors and in neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. His research interests are in the genetics of tumor development within these tumor predisposition syndromes, as well as therapeutic clinical trials for malignant brain tumors. He is also involved in clinical process improvement for brain tumor care at MGH, and contributes to patient care quality measurement development within the American Academy of Neurology and the Society for Neuro-Oncology.
Departments, Centers, & Programs:
Clinical Interests:
- Brain and spinal cord tumors
- Clinical research
- Lymphomas of the nervous system
- Meningiomas
- Neurocutaneous syndrome
- Neurofibromatosis
- Primary brain tumors
Treats:
- Adult & Pediatrics
Languages:
- Spanish
Locations
Mass General Cancer Center in Danvers
102 Endicott St.
Danvers, MA 01923
Phone: 978-882-6060
Mass General Cancer Center: Neuro-Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
Boston, MA 02114
Phone: 617-726-5130
Medical Education
- MD, University of Texas Medical School-Houston
- Residency, UT Southwestern Medical/Parkland
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Neuro-Oncology, United Council for Neurologic Subspecialties
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
Brain Tumors:
- DeWitt JC, Jordan JT, Frosch MP, Iafrate AJ, Louis DN, Lennerz JK. “Cost Effectiveness of IDH Testing in Diffuse Gliomas According to the 2016 WHO-Classification of Tumors of the Central Nervous System Recommendations” Neuro-Oncology. 2017 Nov 29;19(12):1640-1650. PMID29016871
- Jordan JT, Sanders AE, Armstrong T, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality Improvement in Neurology: Neuro-Oncology Quality Measurement Set. Neurology. 2018 Apr 3;90(14)652-658. PMID 29500290. Also published in Neuro-Oncology. 2018 Mar 27;20(4):531-537. PMID 29509930
Neurofibromatosis:
- Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao W, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V. “A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas” OncoTarget. 2015 July 15; 6(19):16981-16997.
- Jordan JT, Smith MJ, Walker JA, Erdin S, Talkowski ME, Merker VL, Ramesh V, Cai W, Harris GJ, Bredella MA, Seijo M, Suuberg A, Guesella JF, Plotkin SR. “Pain Correlates with Germline Mutation in Schwannomatosis.” Medicine. 2018 Feb; 97(5):e9717. PMID 29384852
Another good visit with Dr. Jordan with good results. He understands my anxiety and does not minimize it even though I am stable right now. I trust his judgement and am glad to have him as my neuro-onc.
i am fortunate to have Dr. Jordan as a provider. i have recommended him to friends.
Knowledgeable and attentive
Dr. Jordan is knowledgeable and empathetic.
He genuinely cared about me.
Dr Jordan is a great care provider,listens to what you have to say,very easy to talk too,Great personality A+
Dr Jordan is extremely competent and easy to talk with
Dr. Justin Jordan was wonderful. He answered all of my questions and took me to the information desk to make future visits.
I feel very lucky to be able to see Dr. Jordan. He's, I've seen several doctors for neuro-oncologists and he is, I think, one of the best in the world and a leading researcher and just a great person to talk to. He explains things very clearly, makes me feel supported, is very transparent and with something so serious, I just feel very lucky to ... Read More
I was so impressed with Dr. Jordan. He is incredibly knowledgeable and the kindest doctors I've ever met. He took so much time with me despite being over an hour late. He took his time and explained everything to me. What a wonderful doctor and person. He's so down to earth and made me feel so comfortable. Thank you!